Real-time enrollment status for this advanced solid tumors clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 10:29 AM UTC
| NCT Number | NCT05067283 |
| Recruiting Status | Recruiting |
| Condition | Advanced Solid Tumors |
| Phase | PHASE1 |
| Target Enrollment | 830 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | October 7, 2026 (1 week ago) |
As of October 16, 2026: Clinical trial NCT05067283 is currently recruiting participants. This phase1 study for advanced solid tumors is actively seeking new participants at 6 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05067283 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05067283 was last updated 1 week ago (October 7, 2026). HelloStudys verifies this status automatically.